AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35324910 — intervention group
Group type: EXPERIMENTAL
Intervention: Established community-based VAWG prevention intervention in Ghana
Number of subjects: 6
Study 35324910 — intervention group
Group type: EXPERIMENTAL
Intervention: Livelihoods intervention in South Africa
Number of subjects: 6
Study 35324910 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined small group and community-based programme
Number of subjects: 6
Study 35324910 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based interventions
Number of subjects: 6
Study 35324910 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to financial services in small groups
Number of subjects: 6
Study 35324910 — intervention group
Group type: EXPERIMENTAL
Intervention: Societal perspective interventions with positive economic impacts
Number of subjects: 6
Study 35324910 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness acceptability curves (CEACs)
Number of subjects: 6
Study 37084073 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical activity training
Number of subjects: 62
Study 37084073 — intervention group
Group type: COMPARATOR
Intervention: Aerobic activity training
Number of subjects: 62
Study 33058094 — intervention group
Group type: EXPERIMENTAL
Intervention: DSE technique
Number of subjects: 10
Study 33058094 — intervention group
Group type: COMPARATOR
Intervention: Classic technique
Number of subjects: 10
Study 32013568 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic Resistance Training (HRT; O2 = 14.4%)
Number of subjects: 16
Study 32013568 — intervention group
Group type: COMPARATOR
Intervention: Normoxic Resistance Training (NRT)
Number of subjects: 16
Study 33001439 — intervention group
Group type: EXPERIMENTAL
Intervention: hemocoagulase (group A)
Number of subjects: 910
Study 33001439 — intervention group
Group type: EXPERIMENTAL
Intervention: gentamicin (group B)
Number of subjects: 910
Study 33001439 — intervention group
Group type: EXPERIMENTAL
Intervention: hemocoagulase plus gentamicin (group C)
Number of subjects: 910
Study 33001439 — intervention group
Group type: EXPERIMENTAL
Intervention: normal saline (group D)
Number of subjects: 910
Study 32556827 — intervention group
Group type: EXPERIMENTAL
Intervention: Menopausal Hormone Therapy (MHT)
Number of subjects: 0
Study 32556827 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal, newer low-dose oral therapies, and SERM therapies
Number of subjects: 0
Study 32556827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36377410 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (gPM+)
Number of subjects: 410
Study 36377410 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 410
Study 32533702 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal MRI findings
Number of subjects: 35
Study 32533702 — intervention group
Group type: COMPARATOR
Intervention: Normal MRI findings
Number of subjects: 35
Study 32533702 — intervention group
Group type: COMPARATOR
Intervention: Normal MRI group
Number of subjects: 35
Study 32533702 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal MRI group
Number of subjects: 35
Study 32533702 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal and abnormal MRI groups
Number of subjects: 35
Study 35395866 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor-1 (IGF-1)
Number of subjects: 10
Study 35395866 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study 34461024 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinking according to thirst
Number of subjects: 10
Study 34461024 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum drinking
Number of subjects: 10
Study 32928119 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic needle tip positioning (DNTP)
Number of subjects: 131
Study 32928119 — intervention group
Group type: COMPARATOR
Intervention: Angle-distance (AD)
Number of subjects: 131
Study 33978967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued reflection
Number of subjects: 142
Study 33978967 — intervention group
Group type: EXPERIMENTAL
Intervention: Worked example
Number of subjects: 142
Study 33978967 — intervention group
Group type: COMPARATOR
Intervention: Free reflection
Number of subjects: 142
Study 33978967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued reflection and worked example
Number of subjects: 142
Study 32358375 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine cooperative therapy on the basis of conventional Western medicine
Number of subjects: 0
Study 32358375 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 0
Study 36231486 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic pain management program (eight-week group-based program with four weeks of center-based activities and four weeks of digital-based activities via WhatsApp)
Number of subjects: 0
Study 36231486 — intervention group
Group type: COMPARATOR
Intervention: Usual care and a pain management pamphlet
Number of subjects: 0
Study 35073968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (25 mg/kg every 6 hours for up to 96 hours)
Number of subjects: 40
Study 35073968 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenous 5% dextrose)
Number of subjects: 40
Study 35073968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C
Number of subjects: 40
Study 35073968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34602419 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 75
Study 34602419 — intervention group
Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 75
Study 34602419 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 75
Study 36183143 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological-based cord clamping (PBCC)
Number of subjects: 660
Study 36183143 — intervention group
Group type: COMPARATOR
Intervention: Time-based delayed cord clamping (TBCC)
Number of subjects: 660
Study 34082710 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based sensorimotor home training
Number of subjects: 30
Study 34082710 — intervention group
Group type: COMPARATOR
Intervention: App-based relaxation training (active control)
Number of subjects: 30
Study 34082710 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 30
Study 32188702 — intervention group
Group type: EXPERIMENTAL
Intervention: ?GalCer-pulsed APCs administered intravenously four times
Number of subjects: 35
Study 32188702 — intervention group
Group type: EXPERIMENTAL
Intervention: ?GalCer-pulsed APCs
Number of subjects: 35
Study 35068364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 74
Study 35068364 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 74
Study 35068364 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 74
Study 34913980 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azithromycin, 10 mg/kg once daily for 3 days
Number of subjects: 8266
Study 34913980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8266
Study 32019551 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention targeting diet and physical activity
Number of subjects: 0
Study 32019551 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study 35697280 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 40
Study 35697280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 40
Study 33983395 — intervention group
Group type: EXPERIMENTAL
Intervention: Level B (oxaliplatin 104 mg/m2, capecitabine 500 mg/m2)
Number of subjects: 514
Study 33983395 — intervention group
Group type: EXPERIMENTAL
Intervention: Level C (oxaliplatin 78 mg/m2, capecitabine 375 mg/m2)
Number of subjects: 514
Study 33983395 — intervention group
Group type: COMPARATOR
Intervention: CHEMO-BSC (Level C)
Number of subjects: 514
Study 36297065 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat biscuits enriched with L-arginine (ArgB)
Number of subjects: 0
Study 36297065 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat biscuits enriched with branched-chain amino acids (BCAAsB)
Number of subjects: 0
Study 36297065 — intervention group
Group type: COMPARATOR
Intervention: Conventional wheat biscuit (CB)
Number of subjects: 0
Study 36297065 — intervention group
Group type: COMPARATOR
Intervention: Glucose solution (GS)
Number of subjects: 0
Study 35225436 — intervention group
Group type: EXPERIMENTAL
Intervention: MyLupusGuideTM (immediate access)
Number of subjects: 541
Study 35225436 — intervention group
Group type: COMPARATOR
Intervention: MyLupusGuideTM (delayed access)
Number of subjects: 541
Study 34097705 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical model of heparin clearance for protamine dosing
Number of subjects: 228
Study 34097705 — intervention group
Group type: COMPARATOR
Intervention: Fixed ratio of 1 mg of protamine for every 100 IU of heparin
Number of subjects: 228
Study 35907142 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS reminders
Number of subjects: 54
Study 34030591 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided percutaneous catheter placement and hydrostatic pressure irrigation combined with oral antibiotics
Number of subjects: 12
Study 32475458 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 7.5 mg Cd/kg feed
Number of subjects: 480
Study 32475458 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 15 mg Cd/kg feed
Number of subjects: 480
Study 32475458 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 30 mg Cd/kg feed
Number of subjects: 480
Study 32475458 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 60 mg Cd/kg feed
Number of subjects: 480
Study 36251472 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal-tragus length + 1 cm (group N)
Number of subjects: 120
Study 36251472 — intervention group
Group type: COMPARATOR
Intervention: Weight + 6 cm (group W)
Number of subjects: 120
Study 34474006 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who reported similar/less appetite than before pregnancy
Number of subjects: 1005
Study 34474006 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who were sure they could control cravings
Number of subjects: 1005
Study 32430334 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (anti-PD-L1) monotherapy
Number of subjects: 0
Study 32430334 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 34881553 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (400mg dose of caffeine anhydrous)
Number of subjects: 12
Study 32102535 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacy services
Number of subjects: 0
Study 36086792 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (GCBT)
Number of subjects: 128
Study 36086792 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional treatment only)
Number of subjects: 128
Study 33933058 — intervention group
Group type: EXPERIMENTAL
Intervention: Pigskin suturing model
Number of subjects: 82
Study 33933058 — intervention group
Group type: EXPERIMENTAL
Intervention: Sponge suturing model
Number of subjects: 82
Study 33933058 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial pad suturing model
Number of subjects: 82
Study 33933058 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange suturing model
Number of subjects: 82
Study 33933058 — intervention group
Group type: COMPARATOR
Intervention: All models
Number of subjects: 82
Study 33358119 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled aztreonam lysine plus IV colistimethate (AZLI+IV)
Number of subjects: 16
Study 33358119 — intervention group
Group type: COMPARATOR
Intervention: Dual IV antibiotics (IV+IV)
Number of subjects: 16
Study 34021668 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 12
Study 34021668 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic method
Number of subjects: 12
Study 33436018 — intervention group
Group type: EXPERIMENTAL
Intervention: IBM score based on pre‐treatment contrast‐enhanced CT
Number of subjects: 154
Study 32023545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (HTCWI) at 14°C
Number of subjects: 8
Study 32023545 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot-water immersion (HTHWI) at 39°C
Number of subjects: 8
Study 32023545 — intervention group
Group type: COMPARATOR
Intervention: Heat training (HT)
Number of subjects: 8
Study 32023545 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) at 24°C
Number of subjects: 8
Study 35996967 — intervention group
Group type: EXPERIMENTAL
Intervention: Emblica officinalis extract (EOE) 2 g
Number of subjects: 0
Study 35996967 — intervention group
Group type: EXPERIMENTAL
Intervention: Emblica officinalis extract (EOE) 1 g
Number of subjects: 0
Study 35996967 — intervention group
Group type: COMPARATOR
Intervention: Metformin 500 mg
Number of subjects: 0
Study 34781358 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational Goal Intervention (OGI)
Number of subjects: 0
Study 34781358 — intervention group
Group type: COMPARATOR
Intervention: Craft activities (control)
Number of subjects: 0
Study 32996885 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended periconception lifestyle intervention (combining outpatient lifestyle counseling and eHealth platform) for 24 weeks
Number of subjects: 511
Study 32996885 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended periconception lifestyle intervention (for couples)
Number of subjects: 511
Study 34216833 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking after meals (breakfast, lunch, dinner)
Number of subjects: 14
Study 34216833 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 1
Number of subjects: 14
Study 34216833 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 2
Number of subjects: 14
Study 34216833 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 3
Number of subjects: 14
Study 35100192 — intervention group
Group type: EXPERIMENTAL
Intervention: Titration of inspiratory support to obtain transdiaphragmatic pressure swings in the predefined 'diaphragm-protective' range (3-12 cm H2O)
Number of subjects: 40
Study 35100192 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 40
Study 34021551 — intervention group
Group type: EXPERIMENTAL
Intervention: Internalizing problems (symptoms of depression measured by the shortened CES-D scale)
Number of subjects: 0
Study 34021551 — intervention group
Group type: EXPERIMENTAL
Intervention: Externalizing problems (coexistence of behaviors such as substance abuse, violence, and delinquent behavior)
Number of subjects: 0
Study 34021551 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mental health status
Number of subjects: 0
Study 32611866 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzocaine gel
Number of subjects: 60
Study 32611866 — intervention group
Group type: EXPERIMENTAL
Intervention: Clove-papaya based anesthetic gel
Number of subjects: 60
Study 32611866 — intervention group
Group type: EXPERIMENTAL
Intervention: Precooling with ice
Number of subjects: 60
Study 32611866 — intervention group
Group type: COMPARATOR
Intervention: Ice cone group
Number of subjects: 60
Study 32611866 — intervention group
Group type: COMPARATOR
Intervention: Benzocaine group
Number of subjects: 60
Study 32611866 — intervention group
Group type: COMPARATOR
Intervention: Clove-papaya group
Number of subjects: 60
Study 35151583 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist outreach intervention
Number of subjects: 222
Study 35151583 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 222
Study 32102059 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental fatigue induced by a 90 min incongruent Stroop color word test
Number of subjects: 14
Study 32102059 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive balance test (RBT) accuracy under mental fatigue
Number of subjects: 14
Study 32102059 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional functional performance tests (Y-balance test, single-leg hop, countermovement jump)
Number of subjects: 14
Study 32102059 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuomotor reaction time in the RBT
Number of subjects: 14
Study 36263451 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily emollient plus standard skin-care advice
Number of subjects: 1394
Study 36263451 — intervention group
Group type: COMPARATOR
Intervention: Standard skin-care advice alone
Number of subjects: 1394
Study 33931236 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Severity Index (ESI)
Number of subjects: 23
Study 33931236 — intervention group
Group type: COMPARATOR
Intervention: Japan Triage and Acuity Scale (JTAS)
Number of subjects: 23
Study 34903129 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light exposure (approximately 10000 lux) for 3 hours before sleep
Number of subjects: 10
Study 34903129 — intervention group
Group type: COMPARATOR
Intervention: Control condition (< 50 lux) for 3 hours before sleep
Number of subjects: 10
Study 32886456 — intervention group
Group type: EXPERIMENTAL
Intervention: Low time to surgery (TTS ≤ 5 weeks), n = 27
Number of subjects: 101
Study 32886456 — intervention group
Group type: COMPARATOR
Intervention: High time to surgery (TTS > 5 weeks), n = 74
Number of subjects: 101
Study 32886456 — intervention group
Group type: EXPERIMENTAL
Intervention: Low TTS after propensity matching
Number of subjects: 101
Study 36364898 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C and E supplementation
Number of subjects: 18
Study 36364898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 36364898 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study 34015940 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg once daily for 6 months (n=642)
Number of subjects: 1280
Study 34015940 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=638)
Number of subjects: 1280
Study 32791362 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractions
Number of subjects: 0
Study 32791362 — intervention group
Group type: EXPERIMENTAL
Intervention: Decimals
Number of subjects: 0
Study 32791362 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentages
Number of subjects: 0
Study 32791362 — intervention group
Group type: EXPERIMENTAL
Intervention: Different notations (fractions, decimals, percentages)
Number of subjects: 0
Study 33905304 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape Seed Extract (GSE)
Number of subjects: 0
Study 33905304 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study 34473043 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG + CD133+ implantation
Number of subjects: 26
Study 34473043 — intervention group
Group type: COMPARATOR
Intervention: CABG only
Number of subjects: 26
Study 35797505 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief previsit counseling intervention
Number of subjects: 1270
Study 33919631 — intervention group
Group type: EXPERIMENTAL
Intervention: Cepuna pear (Migo®)
Number of subjects: 15
Study 33919631 — intervention group
Group type: EXPERIMENTAL
Intervention: Conference pear
Number of subjects: 15
Study 32359142 — intervention group
Group type: COMPARATOR
Intervention: 0 g PRO
Number of subjects: 48
Study 32359142 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g PRO
Number of subjects: 48
Study 32359142 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g PRO
Number of subjects: 48
Study 32359142 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 g PRO
Number of subjects: 48
Study 35303461 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiMA strategy (a single programme for both severe acute malnutrition and moderate acute malnutrition using RUTF at a decreasing dose as MUAC and weight increased)
Number of subjects: 896
Study 35303461 — intervention group
Group type: COMPARATOR
Intervention: Standard strategy (one programme for severe acute malnutrition using ready‐to‐use therapeutic food [RUTF] at an increasing dose as weight increased, another for moderate acute malnutrition using a fixed dose of ready‐to‐use supplementary food [RUSF])
Number of subjects: 896
Study 35303461 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiMA strategy
Number of subjects: 896
Study 35303461 — intervention group
Group type: COMPARATOR
Intervention: Standard strategy
Number of subjects: 896
Study 35996891 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates-based exercise classes (four-week, twice-weekly)
Number of subjects: 46
Study 35996891 — intervention group
Group type: COMPARATOR
Intervention: Usual exercise control
Number of subjects: 46
Study 35996891 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates-based exercise classes
Number of subjects: 46
Study 33846987 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater maximum LA volume (Vmax)
Number of subjects: 217
Study 33846987 — intervention group
Group type: EXPERIMENTAL
Intervention: LA emptying fraction in LA conduit phase
Number of subjects: 217
Study 33846987 — intervention group
Group type: EXPERIMENTAL
Intervention: Global and mean segmental peak LA radial strain (RS) and 3D strain (3DS)
Number of subjects: 217
Study 33846987 — intervention group
Group type: EXPERIMENTAL
Intervention: Other strain parameters
Number of subjects: 217
Study 32805081 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy (rituximab schedule)
Number of subjects: 318
Study 32319392 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose bortezomib (0.7 mg/m2) + cyclophosphamide (0.5 g/m2) + dexamethasone
Number of subjects: 58
Study 32319392 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose bortezomib (1.3 mg/m2) + cyclophosphamide (0.5 g/m2) + dexamethasone
Number of subjects: 58
Study 32319392 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib (0.7 mg/m2) + dexamethasone
Number of subjects: 58
Study 32319392 — intervention group
Group type: COMPARATOR
Intervention: Low-dose bortezomib-based therapy
Number of subjects: 58
Study 32319392 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 58